Collegium Pharmaceutical Logo

Collegium Pharmaceutical

🇺🇸
COLL
US19459J1043

Collegium Pharmaceutical is a leading US-based pharmaceutical company specializing in the development and commercialization of innovative medications for pain management. By focusing on patient-centric treatments, the company enhances the quality of life for individuals suffering from chronic pain.

Next Quarterly Earnings

Thursday, November 5, 2026
CW 45
Pre-Market
In 70 days

Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

Quiet period starts on October 8, 2026

Stock Price

Frequently asked questions

When will Collegium Pharmaceutical report its next quarterly earnings?

Collegium Pharmaceutical is scheduled to report its next quarterly earnings on 11/05/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

When did Collegium Pharmaceutical last report quarterly earnings?

Collegium Pharmaceutical last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at 1.92 USD.

How often has Collegium Pharmaceutical beaten expectations?

Collegium Pharmaceutical has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).

How do I add the Collegium Pharmaceutical earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:$1.86
Actual:
Q2 2026
Beat
Estimate:$1.72
Actual:$1.92
Difference:+$0.20
Price reaction (1 day):-18.6 %
Price reaction (7 days):-21.2 %
Q1 2026
Beat
Estimate:$1.52
Actual:$1.76
Difference:+$0.24
Price reaction (1 day):+7.7 %
Price reaction (7 days):-4.6 %
Q3 2025
Missed
Estimate:$2.14
Actual:$2.04
Difference:-$0.10
Q2 2025
Beat
Estimate:$1.86
Actual:$2.25
Difference:+$0.39
Q1 2025
Missed
Estimate:$1.85
Actual:$1.68
Difference:-$0.17

Earnings statistics

Estimates vs. results

3/5
Quarters above estimates
60%
Beat rate
+5.4%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Collegium Pharmaceutical
Ticker Symbol
COLL
ISIN
US19459J1043
Country
🇺🇸
USA
Sector